We are live on ! Find out more
HUMAW

Humacyte Inc Warrant
HUMAW

Delisted

HUMAW was delisted on the 25th of August, 2026.

13 hedge funds and large institutions have $2.45M invested in Humacyte Inc Warrant in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

18% more funds holding

Funds holding: 1113 (+2)

46% less capital invested

Capital invested by funds: $4.55M → $2.45M (-$2.1M)

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
1
Reduced
Closed
9
Calls
$1.89M
Puts
Net Calls
+$1.89M
Net Calls Change
+$1.58M

HUMAW Hedge Fund Activity: Q1 2021 in Review

13 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q1 2021, worth a combined $2.45M — down 46% from $4.55M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new HUMAW positions and 9 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Cowen and Company, adding an estimated $290K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $3.1M sold.

  • 13 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q1 2021, up from 11 in Q4 2020.
  • Funds reported $2.45M of Humacyte Inc Warrant stock for Q1 2021, down 46% quarter-over-quarter.
  • 11 funds opened new Humacyte Inc Warrant positions in Q1 2021 and 9 closed out, a net change of +2 holders.
  • The largest Humacyte Inc Warrant buyer in Q1 2021 was Cowen and Company, an estimated $290K added.
  • The largest Humacyte Inc Warrant seller in Q1 2021 was Boothbay Fund Management, an estimated $3.1M sold.

Based on aggregated 13F filings for Q1 2021.